Trials / Completed
CompletedNCT06066099
Single Ascending Dose, Multiple Ascending Dose, Food Effect Study With AP31969
A Controlled, Randomized, First-In-Human Study of AP31969 Investigating Single and Multiple Ascending Doses and the Effect of Food in Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 92 (actual)
- Sponsor
- Acesion Pharma · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The primary objective of the study is to evaluate the safety and tolerability of single doses (Part A) and multiple doses (Part B) of AP31969 in healthy participants.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | AP31969 | Oral tablets |
| DRUG | Placebo | Oral tablets |
Timeline
- Start date
- 2023-10-04
- Primary completion
- 2025-03-14
- Completion
- 2025-03-14
- First posted
- 2023-10-04
- Last updated
- 2025-07-14
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT06066099. Inclusion in this directory is not an endorsement.